Probiotics and prevention of Clostridium difficile infection.

Goldstein, E J C; Johnson, S J; Maziade, P-J; Evans, C T; Sniffen, J C; Millette, M; McFarland, L V

Goldstein, E J C; Johnson, S J; Maziade, P-J; Evans, C T; Sniffen, J C; Millette, M; McFarland, L V.

Affiliation

Goldstein EJC; R M Alden Research Laboratory, Santa Monica, CA, USA; UCLA School of Medicine, Los Angeles, CA, USA. Electronic address: ejcgmd@aol.com.
Johnson SJ; Loyola School of Medicine, Chicago, IL, USA.
Maziade PJ; Pierre-Le Gardeur Hospital, Quebec, Canada.
Evans CT; Department of Preventive Medicine and Center for Healthcare Studies, Northwestern University, Chicago, IL, USA; Edward Hines Jr VA Hospital, Chicago, IL, USA.
Sniffen JC; Florida Hospital, Orlando, FL, USA.
Millette M; Bio-K Plus International Inc., Laval, Canada.
McFarland LV; Department of Medicinal Chemistry, University of Washington, Seattle, WA, USA.

Anaerobe ; 45: 114-119, 2017 Jun.

Article de En | MEDLINE | ID: mdl-27988389

Sujet(s)
Mots clés

Bio-K+; C. difficile; Lactobacillus acidophilus CL1285; Lactobacillus casei LBC80R; Lactobacillus rhamnosus CLR2; Lactobacillus rhamnosus GG; Probiotic; Saccharomyces boulardii

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à Clostridium / Probiotiques Limites: Humans Langue: En Journal: Anaerobe Année: 2017 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google